Hundreds of children with severe epilepsy will be able to benefit from a groundbreaking new treatment on the NHS that could significantly reduce their seizures, providing new hope for them and their families.
The drug, fenfluramine, will be funded for NHS patients in England from today (Thursday 20 February) after the National Institute for Health and Care Excellence (NICE) recommended it for seizures associated with Lennox–Gastaut syndrome (LGS) in people aged 2 years and over…
